154 related articles for article (PubMed ID: 12660548)
1. Renal lesions in HIV-1-positive patient treated with tenofovir.
Créput C; Gonzalez-Canali G; Hill G; Piketty C; Kazatchkine M; Nochy D
AIDS; 2003 Apr; 17(6):935-7. PubMed ID: 12660548
[No Abstract] [Full Text] [Related]
2. Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution.
Gaspar G; Monereo A; García-Reyne A; de Guzmán M
AIDS; 2004 Jan; 18(2):351-2. PubMed ID: 15075563
[No Abstract] [Full Text] [Related]
3. Tenofovir-related nephrotoxicity in HIV-infected patients.
Barrios A; García-Benayas T; González-Lahoz J; Soriano V
AIDS; 2004 Apr; 18(6):960-3. PubMed ID: 15060449
[No Abstract] [Full Text] [Related]
4. Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir.
Callens S; De Roo A; Colebunders R
J Infect; 2003 Oct; 47(3):262-3. PubMed ID: 12963392
[No Abstract] [Full Text] [Related]
5. Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.
Breton G; Alexandre M; Duval X; Prie D; Peytavin G; Leport C; Vildei JL
Scand J Infect Dis; 2004; 36(6-7):527-8. PubMed ID: 15307594
[TBL] [Abstract][Full Text] [Related]
6. Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity.
Coca S; Perazella MA
Am J Med Sci; 2002 Dec; 324(6):342-4. PubMed ID: 12495304
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir-related nephrotoxicity: case report and review of the literature.
James CW; Steinhaus MC; Szabo S; Dressier RM
Pharmacotherapy; 2004 Mar; 24(3):415-8. PubMed ID: 15040657
[TBL] [Abstract][Full Text] [Related]
8. An unrecognised case of tenofovir-associated Fanconi syndrome.
Gracey DM; Fernando M; Ziegler J; White CP; Post JJ
Med J Aust; 2012 Feb; 196():111-2. PubMed ID: 22304601
[No Abstract] [Full Text] [Related]
9. Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity?
Saumoy M; Vidal F; Peraire J; Sauleda S; Vea AM; Viladés C; Ribera E; Richart C
AIDS; 2004 Aug; 18(12):1741-2. PubMed ID: 15280790
[No Abstract] [Full Text] [Related]
10. Acute tubular necrosis in a patient receiving tenofovir.
Lee JC; Marosok RD
AIDS; 2003 Nov; 17(17):2543-4. PubMed ID: 14600530
[No Abstract] [Full Text] [Related]
11. Incidence of proximal renal tubular dysfunction in patients on tenofovir disoproxil fumarate.
Quinn KJ; Emerson CR; Dinsmore WW; Donnelly CM
Int J STD AIDS; 2010 Feb; 21(2):150-1. PubMed ID: 20090006
[No Abstract] [Full Text] [Related]
12. Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure.
Rifkin BS; Perazella MA
Am J Med; 2004 Aug; 117(4):282-4. PubMed ID: 15308442
[No Abstract] [Full Text] [Related]
13. Tenofovir disoproxil fumarate.
Kumar A
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887267
[No Abstract] [Full Text] [Related]
14. Tenofovir disoproxil fumarate.
Antoniou T
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887266
[No Abstract] [Full Text] [Related]
15. Fanconi syndrome and renal failure induced by tenofovir: a first case report.
Verhelst D; Monge M; Meynard JL; Fouqueray B; Mougenot B; Girard PM; Ronco P; Rossert J
Am J Kidney Dis; 2002 Dec; 40(6):1331-3. PubMed ID: 12460055
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir-induced renal tubular dysfunction presenting with hypocalcaemia.
Williams J; Chadwick DR
J Infect; 2006 Apr; 52(4):e107-8. PubMed ID: 16125779
[No Abstract] [Full Text] [Related]
17. Warning issued on non-response rates.
AIDS Patient Care STDS; 2003 Oct; 17(10):539. PubMed ID: 14588094
[No Abstract] [Full Text] [Related]
18. Evolution of lipid abnormalities in patients switched from stavudine- to tenofovir-containing regimens.
Lafeuillade A; Jolly P; Chadapaud S; Hittinger G; Lambry V; Philip G
J Acquir Immune Defic Syndr; 2003 Aug; 33(4):544-6. PubMed ID: 12869846
[No Abstract] [Full Text] [Related]
19. Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature.
Haverkort ME; van der Spek BW; Lips P; Slieker WA; ter Heine R; Huitema AD; Bronsveld W
Scand J Infect Dis; 2011 Oct; 43(10):821-6. PubMed ID: 21563880
[TBL] [Abstract][Full Text] [Related]
20. Toward a pharmacogenetic understanding of nucleotide and nucleoside analogue toxicity.
Hulgan T; Haas DW
J Infect Dis; 2006 Dec; 194(11):1471-4. PubMed ID: 17083029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
